President & CEO
Missing a competitor? Contribute!
Charles River is a top competitor of Envigo. Charles River was founded in 1947, and is headquartered in Wilmington, Massachusetts. Like Envigo, Charles River also competes in the Medical Research & Laboratories field. Charles River generates $2.5B more revenue vs. Envigo.
LabCorp is seen as one of Envigo's top competitors. LabCorp is headquartered in Burlington, North Carolina, and was founded in 1905. Like Envigo, LabCorp also operates in the Medical Research & Laboratories field. LabCorp generates 3,063% the revenue of Envigo.
Eurofins has been one of Envigo's top competitors. Eurofins's headquarters is in Luxembourg, Luxembourg, and was founded in 1987. Eurofins is in the Biotechnology industry. Eurofins generates 1,336% of Envigo's revenue.
Weigh-in!Help the Owler community know more
Competitor - 1/1
Is SGS a competitor of Envigo?
Trending News for Envigo and Envigo's Competitors
Animal Research Models Business, Horizon Discovery Group plc
These are all the companies that Envigo has acquired. Envigo's latest acquisition was Animal Research Models Business, Horizon Discovery Group plc in Nov 2019.
Envigo Funding History
No recent funding data found related to Envigo
No recent investments found related to Envigo
These are all the companies that Envigo has invested in. Envigo's latest investment was Animal Research Models Business, Horizon Discovery Group plc in Nov 2019.
June 5, 2019Pharmabiz
LabCorp completes acquisition of Envigo's global nonclinical contract research business
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, an... See more » April 23, 2019BioPortfolio
LabCorp Envigo deal will see both companies focus and expand respective expertise
LabCorps Covance Drug Development segment is set to acquire Envigos nonclinical research services bus... See more » April 20, 2019Pharmabiz
LabCorp, Envigo ink agreement to expand nonclinical drug development capabilities
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, an... See more » April 18, 2019WRAL TechWire
Hundreds of employees to swap companies in complex $485M LabCorp deal
Hundreds of employees will be swapping companies as part of a $485 million deal life science giant La... See more » March 12, 2019Contract Pharma
Envigo Launches PATHWAY
Designed to optimize non-clinical safety assessment programs... See more » March 11, 2019Applied Clinical Trials
Envigo launches PATHWAY
Envigo, a provider of non-clinical contract research services and research models, announced PATHWAY ... See more » March 11, 2019Outsourcing-Pharma
Envigo paves new first-in-human trial solution
The non-clinical contract research services and research model provider Envigo launches a new solutio... See more »
October 14, 2020Envigo Blog
Progress in diets to induce nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing, with ~24% of the US and Eur... See more » September 14, 2020Envigo Blog
Patient-derived xenograft: making personalized medicine even more personal
It is well established that personalized medicine can overcome some limitations of a one-size-fits-al... See more » August 4, 2020Envigo Blog
Cryopreservation and rederivation: Two steps forward, no setback
Effective colony management ensures reproducible research outcomes and adherence to the principles of... See more » June 17, 2020Envigo Blog
How COVID-19 has changed the biomedical industry
The shift in research priorities due to COVID-19 has required rapid adjustment across the biomedical ... See more » May 18, 2020Envigo Blog
4 tips to help secure research funding
Securing research funding is becoming increasingly difficult with the ever-growing competition across... See more » April 21, 2020Envigo Blog
Rodents in research: is 2020 the year of the lab rat?
Lab rats and mice have been used for decades to make great medical advances, from HIV antiretrov... See more » March 9, 2020Envigo Blog
Care and husbandry for immunodeficient rodents: guidance to reduce risks in your research
Immunodeficient rodents can serve as a valuable part of basic research studies to help researchers be... See more »
Envigo is a provider of non-clinical research and development and regulatory consulting services to pharmaceutical and chemical industries. Envigo was founded in 2015. Envigo's headquarters is located in Indianapolis, Indiana, USA 46250. Envigo's late... Envigo's President & CEO, Adrian Hardy, currently has an approval
rating of 89%. Envigo's primary competitors are Charles River, LabCorp & Eurofins.
Frequently Asked Questions about Envigo
When was Envigo founded?Envigo was founded in 2015
Who is Envigo's CEO?Envigo's CEO is Adrian Hardy
How much revenue does Envigo generate?Envigo generates $500M in revenue
How much funding does Envigo have?Envigo has historically raised $0 in funding
Where is Envigo's headquarters?Envigo's headquarters is in Indianapolis Indiana, USA
How many employees does Envigo have?Envigo has 1,200 employees
What sector does Envigo operate in?Envigo is in Pharmaceuticals, Medical Research & Laboratories
Who are Envigo's competitors?Envigo's top competitors are Charles River, LabCorp, Eurofins